Skip to main content
VCbacked
Log inGet Started

BioMAdvanced Diagnostics

Nantes, France

BioMAdvanced Diagnostics is a developer of molecular diagnostic and biomarker tests.

$1.6M raised
Jul 2023
Venture - Series Unknown
MedicalMedical Device

Top Investors

BpifrancePays de la Loire ParticipationsSodero GestionAtlantique Vendée Innovation

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BioMAdvanced Diagnostics

How much funding has BioMAdvanced Diagnostics raised?
BioMAdvanced Diagnostics has raised $1.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2023.
Who are BioMAdvanced Diagnostics's investors?
BioMAdvanced Diagnostics's investors include Bpifrance, Pays de la Loire Participations, Sodero Gestion, Atlantique Vendée Innovation.
Where is BioMAdvanced Diagnostics headquartered?
BioMAdvanced Diagnostics is headquartered in Nantes, France.
What does BioMAdvanced Diagnostics do?
BioMAdvanced Diagnostics is a developer of molecular diagnostic and biomarker tests.
What stage is BioMAdvanced Diagnostics at?
BioMAdvanced Diagnostics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"BioMAdvanced Diagnostics — Funding & Investors." VCBacked, July 14, 2023, https://www.vcbacked.co/company/biomadvanced-diagnostics. Accessed July 2, 2026.
APA
VCBacked. (2023). BioMAdvanced Diagnostics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/biomadvanced-diagnostics
Wikipedia (cite web)
{{cite web |title=BioMAdvanced Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/biomadvanced-diagnostics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Medical

View all
Oryl Photonics
Lausanne
OncoRevive
Brunswick$119K
Rapport Therapeutics
Boston$250.0M
Novostia
Epalinges$6.6M
Zyppah
Las Vegas$151K
Advanced Microbiome Interventions
Amsterdam$300K